Veterinary Medicines

Quiflor 100 mg/ml solution for injection for cattle and pigs (sows)

Authorised
  • Marbofloxacin
Download as PDF

Product identification

Medicine name:
QUIFLOR 100MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Quiflor 100 mg/ml solution for injection for cattle and pigs (sows)
Active substance:
  • Marbofloxacin
Target species:
  • Cattle
  • Pig (sow for reproduction)
Route of administration:
  • Intravenous use
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Marbofloxacin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        36
        hour
      • Meat and offal
        6
        day
  • Subcutaneous use
    • Cattle
      • Milk
        36
        hour
      • Meat and offal
        6
        day
  • Intramuscular use
    • Cattle
      • Milk
        36
        hour
      • Meat and offal
        6
        day
    • Pig (sow for reproduction)
      • Meat and offal
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:
  • (ID3) 50 millilitre(s): unspecified outer container with 1 Vial (Braunglas) with 50 millilitre(s), closed with Stopfen (bromobutyl rubber`)
  • (ID2) 100 millilitre(s): unspecified outer container with 1 Vial (Braunglas) with 100 millilitre(s), closed with Stopfen (bromobutyl rubber`)
  • (ID1) 250 millilitre(s): unspecified outer container with 1 Vial (Braunglas) with 250 millilitre(s), closed with Stopfen (bromobutyl rubber`)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
  • TAD Pharma GmbH
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 86458/10-11-2016/K-0189202
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0302/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Greece
  • Italy
  • Lithuania
  • Netherlands
  • Portugal
  • Slovakia
  • Spain